A new blood test has an 80% accuracy in predicting preterm preeclampsia, according to a study published today, Feb. 12, in ...
"A lot of immunocompromised patients are not stable enough to undergo these invasive ... More information: Anthony Lieu et al, Concordance of non-invasive plasma cell-free DNA with invasive ...
Upper tract urothelial carcinoma (UTUC) is an aggressive disease that is challenging to biopsy and diagnose, frequently yielding nondiagnostic cytology and tissue specimens. Therefore, UTUC is often ...
Minimally invasive genomic sequencing of circulating tumor DNA (ctDNA) can be performed using ... in patients after definitive radical surgery, did not meet its primary end point of disease-free ...
Explore how psychosocial and physical stress affects cfDNA release in blood and saliva. Discover gender differences and ...
Due to its proximity to humans, it regularly, although involuntarily hitches a ride on ships and planes, eventually invading ...
Natera, Inc. , a global leader in cell-free DNA and genetic testing, today commented on recent updates by the NCCN on circulating tumor DNA (ctDNA) molecular residual disease (MRD) testing in the ...
Guardant Health is overcoming skepticism with new cancer tests. Learn why GH stock is a buy, with strong growth and a shift ...
Currently, bAVM somatic mutation genetic characterization requires sequencing surgically excised lesion DNA, but recent advancements have overcome some conventional biopsy limitations through ...